Your browser doesn't support javascript.
loading
Preclinical evaluation of novel PI3K/mTOR dual inhibitor SN202 as potential anti-renal cancer agent.
Wang, Wan; Liao, Lidong; Wang, Yujun; Li, Hui; Suo, Zili; Long, Kai; Tang, Peixiao.
Afiliação
  • Wang W; a College of Chemical Engineering, Sichuan University , Chengdu , PR China.
  • Liao L; b Sichuan Sinovation Bio-technology Co., LTD , Chengdu , PR China.
  • Wang Y; b Sichuan Sinovation Bio-technology Co., LTD , Chengdu , PR China.
  • Li H; a College of Chemical Engineering, Sichuan University , Chengdu , PR China.
  • Suo Z; a College of Chemical Engineering, Sichuan University , Chengdu , PR China.
  • Long K; b Sichuan Sinovation Bio-technology Co., LTD , Chengdu , PR China.
  • Tang P; a College of Chemical Engineering, Sichuan University , Chengdu , PR China.
Cancer Biol Ther ; 19(11): 1015-1022, 2018.
Article em En | MEDLINE | ID: mdl-29799306
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Cancer Biol Ther Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Cancer Biol Ther Ano de publicação: 2018 Tipo de documento: Article